Patent · US Active

5-aminopyrazole-4-carboxamide inhibitors of CDPK1 from T. gondii and C. parvum

US9956214B2 · kind B2 · utility

1Cited by

4References

20Claims

0Family size

Assignee

University of Washington through its Center for Commercialization · US

Inventors

Erkang Fan · Shoreline, US
Wesley C. Van Voorhis · Seattle, US
Zhongsheng Zhang · Seattle, US
Wenlin Huang · Seattle, US
Kayode K. Ojo · Federal Way, US

Key dates

Filing date	Nov 15, 2016
Grant date	May 1, 2018
Priority date	—
Expiry date	Nov 15, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is generally directed to compositions and methods for treating apicomplexan protozoan related disease, such as toxoplasmosis and cryptosporidiosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.